{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:03:07Z","timestamp":1791154987300,"version":"4.1.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation"],"published-print":{"date-parts":[[1995,1,15]]},"abstract":"<jats:p>\n            <jats:italic>Background<\/jats:italic>\n            Our objective was to compare the sensitivity and specificity of tetrofosmin, a new\n            <jats:sup>99m<\/jats:sup>\n            Tc-labeled myocardial perfusion imaging agent for the detection of myocardial perfusion abnormalities, with those of\n            <jats:sup>201<\/jats:sup>\n            Tl and coronary angiography. Our hypothesis was that same-day stress\/rest tetrofosmin imaging could provide data comparable to those of\n            <jats:sup>201<\/jats:sup>\n            Tl imaging. Myocardial perfusion imaging plays an important role for the evaluation of coronary artery disease. Newer\n            <jats:sup>99m<\/jats:sup>\n            Tc-labeled agents offer several advantages over\n            <jats:sup>201<\/jats:sup>\n            Tl, the conventional myocardial perfusion imaging agent. Tetrofosmin is a new\n            <jats:sup>99m<\/jats:sup>\n            Tc-labeled agent with promising results in preliminary studies.\n          <\/jats:p>\n          <jats:p>\n            <jats:italic>Methods and Results<\/jats:italic>\n            Two hundred fifty-two patients with suspected coronary artery disease were enrolled in 10 centers in the United States and Europe. All patients underwent exercise and rest myocardial perfusion imaging with\n            <jats:sup>99m<\/jats:sup>\n            Tc-tetrofosmin using two separate injections of the radiotracer 4 hours apart on the same day. Planar images were obtained in three standard views 15 to 60 minutes after radiotracer injection. Patients also underwent standard exercise and redistribution planar\n            <jats:sup>201<\/jats:sup>\n            Tl imaging within 2 weeks of tetrofosmin imaging. In addition, 58 healthy subjects with low likelihood of coronary artery disease underwent exercise and rest tetrofosmin imaging. Coronary angiograms were available in 181 patients with suspected coronary artery disease. All radionuclide images were processed in the central core laboratory and interpreted blindly by a panel of four experienced readers.\n            <jats:sup>201<\/jats:sup>\n            Tl images and tetrofosmin images were read separately. Discrepancies were resolved by consensus. The workload, peak heart rate, and double products were comparable during exercise for both imaging agents. Technically acceptable paired\n            <jats:sup>201<\/jats:sup>\n            Tl and tetrofosmin images were available in 224 of 252 patients. Tetrofosmin images were generally of good quality, with low extracardiac activity, and easy to interpret. Patients were categorized as showing normal, ischemia, infarction, or mixture with each imaging modality. Precise concordance for each of these categories was 59.4% (\u03ba=0.44; 95% CI, 0.35 to 0.53). When patients were categorized as normal or abnormal, the concordance was 80.4% (\u03ba=0.55; 95% CI, 0.43 to 0.67). When each of five anatomic territories (septal, anterior, inferior, lateral, and apical) was categorized as normal versus abnormal, the concordance varied from 81% to 90%. When similar comparison was made for the specific category of abnormality, the concordance was 64% to 84%. When coronary angiography was used as the criterion, the sensitivity and positive and negative predictive accuracy of tetrofosmin and\n            <jats:sup>201<\/jats:sup>\n            Tl were comparable. The normalcy rate of tetrofosmin images in the healthy subjects with low likelihood of coronary artery disease was 97%.\n          <\/jats:p>\n          <jats:p>\n            <jats:italic>Conclusions<\/jats:italic>\n            <jats:sup>99m<\/jats:sup>\n            Tc tetrofosmin is a new myocardial imaging agent with favorable imaging characteristics with results comparable to those of\n            <jats:sup>201<\/jats:sup>\n            Tl.\n          <\/jats:p>","DOI":"10.1161\/01.cir.91.2.313","type":"journal-article","created":{"date-parts":[[2012,6,12]],"date-time":"2012-06-12T00:34:42Z","timestamp":1339461282000},"page":"313-319","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":139,"title":["Myocardial Perfusion Imaging With\n            <sup>99m<\/sup>\n            Tc Tetrofosmin"],"prefix":"10.1161","volume":"91","author":[{"given":"Barry L.","family":"Zaret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Rigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans J.T.","family":"Wackers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Hendel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon H.","family":"Braat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami S.","family":"Iskandrian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangalore S.","family":"Sridhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diwakar","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Itti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo N.","family":"Serafini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Goris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avijit","family":"Lahiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309093291107"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.51.4.1116254"},{"key":"e_1_3_2_3_2","first-page":"301","volume":"30","year":"1989","unstructured":"Wackers FJ, Berman DS, Maddahi J, et al. Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med. 1989;30:301-311.","journal-title":"J Nucl Med"},{"key":"e_1_3_2_4_2","first-page":"1","volume":"17","year":"1989","unstructured":"Kiat H, Maddahi J, Roy LT, et al. Comparison of technetium 99m methoxy isonitrile and thallium 201 for evaluation of coronary artery disease by planar and tomographic methods. Am Heart J. 1989;17:1-11.","journal-title":"Am Heart J"},{"key":"e_1_3_2_5_2","first-page":"222","volume":"34","year":"1993","unstructured":"Kelly JD, Forster AM, Higley B, et al. Technetium-99m tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging. J Nucl Med. 1993;34:222-227.","journal-title":"J Nucl Med"},{"key":"e_1_3_2_6_2","unstructured":"Sinusas AJ Shi QX Saltzberg MT et al. Technetium-99m tetrofosmin to assess myocardial blood flow: experimental validation in an intact canine model of ischemia. J Nucl Med. 1994;35:664-667."},{"key":"e_1_3_2_7_2","first-page":"30","volume":"34","year":"1993","unstructured":"Higley B, Smith FW, Smith T, et al. Technetium-99m-1,2{bis(2-ethoxyethyl)phosphine}ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med. 1993;34:30-38.","journal-title":"J Nucl Med"},{"key":"e_1_3_2_8_2","first-page":"1254","volume":"34","year":"1993","unstructured":"Jain D, Wackers FJ, Mattera J, McMahon M, Sinusas AJ, Zaret BL. Biokinetics of 99m Tc-tetrofosmin, myocardial perfusion imaging agent: implications for a one day imaging protocol. J Nucl Med. 1993;34:1254-1259.","journal-title":"J Nucl Med"},{"key":"e_1_3_2_9_2","first-page":"202A","volume":"19","year":"1992","unstructured":"Sridhara BS, Braat S, Itti R, Rigo P, Cload P, Lahiri A. Early and late myocardial imaging with a new technetium-99m diphosphine (PPN 1011) in coronary artery disease. J Am Coll Cardiol. 1992;19:202A. Abstract.","journal-title":"J Am Coll Cardiol"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02984085"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02940009"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197906143002402"},{"key":"e_1_3_2_13_2","first-page":"759","volume":"32","year":"1991","unstructured":"Sigal SL, Soufer R, Fetterman RC, Mattera JA, Wackers FJ. Reproducibility of quantitative planar thallium-201 scintigraphy: quantitative criteria for reversibility of myocardial perfusion defects. J Nucl Med. 1991;32:759-765.","journal-title":"J Nucl Med"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(89)90456-7"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.2307\/2529310"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(93)90226-Q"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198309013090902"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198811173192002"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(91)90752-U"},{"key":"e_1_3_2_20_2","unstructured":"Iskandrian AS Heo J. Pharmacologic stress testing. In: Zaret BL Beller GA eds. Nuclear Cardiology: State of the Art and Future Directions. St Louis Mo: Mosby; 1993:170-180."},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.86.1.1617793"}],"container-title":["Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.CIR.91.2.313","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T16:07:03Z","timestamp":1715530023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.CIR.91.2.313"}},"subtitle":["Comparison to\n            <sup>201<\/sup>\n            Tl Imaging and Coronary Angiography in a Phase III Multicenter Trial"],"short-title":[],"issued":{"date-parts":[[1995,1,15]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1995,1,15]]}},"alternative-id":["10.1161\/01.CIR.91.2.313"],"URL":"https:\/\/doi.org\/10.1161\/01.cir.91.2.313","relation":{},"ISSN":["0009-7322","1524-4539"],"issn-type":[{"value":"0009-7322","type":"print"},{"value":"1524-4539","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,1,15]]},"assertion":[{"value":"1994-11-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1994-11-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1995-01-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}